Menu

  • Donate
  • Warriors
  • Chapters
  • Events
  • News
  • Brain Tumors
    • About Brain Tumors
    • Brain Tumor Symptoms
    • Brain Tumor Facts
  • Family Support
    • Warrior Program
    • Families Helping Families
    • Financial Support
  • How to Help
    • Get Involved
    • Ways to Give
    • Fundraise
    • Partnerships
    • Employer Match
    • Payroll Giving
    • Attend an Event
    • Awareness Page
    • Promising Pathway Act
    • Shop
  • Research
    • Research & Grants
    • DIPG/DMG Collaborative
  • Who We Are
    • Our Mission
    • Our History
    • Our Success
    • Our Chapters
    • Financials
    • The Councils
    • Staff
    • Contact Us
           
Logo
Logo
  • Warriors
  • Chapters
  • Events
  • Donate
  • Brain Tumors
    • About Brain Tumors
    • Brain Tumor Symptoms
    • Brain Tumor Facts
  • Family Support
    • Warrior Program
    • Families Helping Families
    • Financial Support
  • How to Help
    • Get Involved
    • Ways to Give
    • Fundraise
    • Partnerships
    • Employer Match
    • Payroll Giving
    • Attend an Event
    • Awareness Page
    • Promising Pathway Act
    • Shop
  • Research
    • Research & Grants
    • DIPG/DMG Collaborative
  • Who We Are
    • Our Mission
    • Our History
    • Our Success
    • Our Chapters
    • Financials
    • The Councils
    • Staff
    • Contact Us

Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

Grant Approval Process

Grant Approval Process


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.





  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

University of Queensland Diamantina Institute – $100,000 USD / $136,000 AUD (Approx)

Amount
$100,000.00 USD
Date
September 2021

Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma

Grant Information

Duke University Hospital – $50,000

Amount
$50,000.00 USD
Date
September 2021

Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors

Grant Information

Funding of PBTCF 2021: PBTC-059 - $25,000

Amount
$25,000.00 USD
Date
January 2021

Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma

Grant Information

International DIPG/DMG Registry And Repository - $1,508,198

Amount
$1,508,198.00 USD
Date
December 2020

Grant Information

Children's Cancer Institute - $99,251 USD / $140,212 AUD (Approx)

Amount
$99,251.00 USD
Date
September 2020

Discovering New Epigenetic Players in DIPG Oncogenesis

Grant Information

Northwestern Memorial Hospital - $110,000

Amount
$110,000.00 USD
Date
September 2020

Development of Histone Demethylase Inhibitor Against DIPG

Grant Information

The Hospital for Sick Children - $100,000

Amount
$100,000.00 USD
Date
September 2020

Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma

Grant Information

Hunter Medical Research Institute - $145,640 USD / $199,527 AUD (Approx)

Amount
$145,640.00 USD
Date
September 2020

Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas

Grant Information

CONNECT Consortium - $489,801.26

Amount
$489,801.00 USD
Date
September 2020

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

Grant Information

International DIPG/DMG Registry And Repository - $862,671

Amount
$862,671.00 USD
Date
May 2020

Grant Information

Funding of PBTCF 2020: PBTC-058 - $25,000

Amount
$25,000.00 USD
Date
January 2020

PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Grant Information

Sydney Children's Hospital - $151,468 USD / $219,386 AUD (Approx)

Amount
$151,468.00 USD
Date
December 2019

Developing New Epigenetic Combination Treatments Against DIPG.

Grant Information

Oncoceutics ONC201 - $100,000

Amount
$100,000.00 USD
Date
December 2019

Expansion of the ONC201 Compassionate Use.

Grant Information
Learn More

University of Sydney - $100,000 USD / $146,520 AUD (Approx)

Amount
$100,000.00 USD
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

Grant Information

University of Michigan Hospitals - $157,856

Amount
$157,856.00 USD
Date
November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Grant Information
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

Donate Today & Become A Hero

Donate
The Cure Starts Now Logo
See The Impact
Warriors
Who We Are
Get Involved
Contact Us
Donate
Find A Chapter

Candid Great Nonprofits Charity Navigator DIPG/DMG Collaborative Foundational Partner
           
Brain Tumors
  • About Brain Tumors
  • Brain Tumor Symptoms
  • Brain Tumor Facts
Family Support
  • Warrior Program
  • Families Helping Families
  • Financial Support
How to Help
  • Get Involved
  • Ways to Give
  • Fundraise
  • Partnerships
  • Employer Match
  • Payroll Giving
  • Attend an Event
  • Awareness Page
  • Promising Pathway Act
  • Shop
Research
  • Research & Grants
  • DIPG/DMG Collaborative
Who We Are
  • Our Mission
  • Our History
  • Our Success
  • Our Chapters
  • Financials
  • The Councils
  • Staff
  • Contact Us
Contact Us
  •                

  • Candid Great Nonprofits Charity Navigator DIPG/DMG Collaborative Foundational Partner

The Cure Starts Now Cancer Resource Network:
The Cure Starts Now | DIPG.org | Medulloblastoma.org

© 2026 The Cure Starts Now | 10280 Chester Road, Cincinnati, Ohio 45215 | 513-772-4888 | Privacy Policy
Registered 501(c)(3) | FEIN: 26-0269131